(Q53254321)

English

A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous rese

scientific article published on 8 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous rese (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

chemoradiotherapy

0 references

phase III clinical trial

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

10

object named as

P Arveux

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

author name string

F Bonnetain

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

O Bouché

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

P Michel

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

C Mariette

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

T Conroy

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

D Pezet

6

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

B Roullet

7

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

J-F Seitz

8

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

B Paillot

9

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

C Milan

11

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

L Bedenne

12

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

publication date

8 March 2006

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

Annals of Oncology

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

17

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

827-834

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

Esophageal Cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

The role of surgery in the management of oesophageal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Quality of life measurement in patients with oesophageal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Quality of life end points in cancer clinical trials: review and recommendations

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Cancer outcomes research

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Assessing quality of life in clinical research: from where have we come and where are we going?

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Measuring the quality of life of cancer patients: a concise QL-index for use by physicians.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Critical review of the international assessments of health-related quality of life

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Substituting proxy ratings for patient ratings in cancer clinical trials: an analysis based on a Southwest Oncology Group trial in patients with brain metastases.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Practical approaches to minimize problems with missing quality of life data

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Missing quality of life data in cancer clinical trials: serious problems and challenges

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Observer variation in assessment of quality of life in patients with oesophageal cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Clinical relevance of single item quality of life indicators in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

An approach to the analysis of repeated measurements.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Effects of altering the time of administration and the time frame of quality of life assessments in clinical trials: an example using the EORTC QLQ-C30 in a large anti-emetic trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

The prognostic value of quality of life scores during treatment for oesophageal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Interpreting the significance of changes in health-related quality-of-life scores.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Comparison of several model-based methods for analysing incomplete quality of life data in cancer clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Pattern mixture models for longitudinal quality of life studies in advanced stage disease

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Growth curve model analysis for quality of life data.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Longitudinal quality of life study in patients with metastatic gastric cancer. Analysis modalities and clinical applicability of QoL in randomized phase II trial in a digestive oncology

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Value of caregiver ratings in evaluating the quality of life of patients with cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Comparison of patient and proxy EORTC QLQ-C30 ratings in assessing the quality of life of cancer patients.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Evaluation of quality of life in clinical trials. Selecting quality-of-life measures

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Histologic Tumor Type Is an Independent Prognostic Parameter in Esophageal Cancer: Lessons From More Than 1,000 Consecutive Resections at a Single Center in the Western World

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDL033

21 January 2018

Identifiers

10.1093/ANNONC/MDL033

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16524973

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53254321&oldid=1247633765"